Parts of Indian Himalayan region vulnerable to major quakes

July 18, 2013
Hyderabad, July 18: Parts of the Indian Himalayan region are facing the risk of major earthquakes in the future, according to a study conducted by city-based National Geophysical Research Institute (NGRI). himalaya

"The conclusion was reached following seismic imaging (similar to human body imaging) of the Kumaon-Garhwal region in Uttarakhand for the purpose of the study," Shyam Rai, Chief Scientist (Seismic Tomography), who led the team of NGRI scientists, told PTI.

The study, also contributed by Stanford University of United States, was conducted from April, 2005 to June, 2008 as sought by the Union government and the initial report was submitted in 2010. However, full details regarding seismic imaging and other aspects of the study were found out subsequently.

Asked if recent heavy rains in Uttarakhand were anyway related to the findings, he replied in the negative but said they are coupled systems.

"Uttarakhand was chosen because space measurements were available, which show that the strain build-up is maximum in this area. So, the chance of having an earthquake also is maximum. So, they wanted to know where the earthquakes are occurring. Also, in Kumaon, there was a major earthquake in 1803," Rai said.

Quoting from British Gazettes of the date, he said the effects of the 1803 quake were felt right up to Lucknow.

"If nothing bigger, even if that has to occur now, with this whole bunch of new constructions and dams and large population, the effect would be far more severe. It is in this context, the government decided that we should have a proper monitoring," Rai said.

He said that several destructive earthquakes had occurred along the part of Indian Himalayan belt – from Jammu and Kashmir to Arunachal Pradesh.

Geophysicists found that 90 per cent of earthquakes were concentrated along a line that passes through Badrinath, Kedarnath and goes up to north-west Himalayas.

NGRI, under the Council of Scientific and Industrial Research (CSIR), is the country's largest research and development organisation.

It is generally felt that earthquakes are likely to occur in the region where they have already taken place.

"It is always said that India is going down beneath Asia and that's what basically causing all earthquakes...So, it will be going down at some angle. If this angle is very smooth, then the chances of any energy concentration would be very low. But if the angle becomes high, then there is a stronger chance of energy concentration, where it is bending," Rai explained.

Earlier, it was said that India was "going down" at something like 4-5 degrees which was smooth. However, when we tried to image this, we found that this is not true," Rai said.

The observation made by the NGRI team was that the seismic development was taking place at the steep angle of 16 degrees.

"From flat to very steep, the energy concentration would always be much higher.

This is happening closer to Chamoli. A couple of years back, we had a sequence of quakes in Uttarkashi, Chamoli, and most of them happened where it is bending.

"This is the precise reason why we made the statement that this is bending and bending at a much steeper angle," the chief economist said.

He said the geophysical activity in the area makes it vulnerable to big tremors."...The chance of energy concentration is going to be much higher. Energy concentration is continuously going on and no big earthquake is coming.

"That means, continuously energy is being stored at that location. But, it cannot happen indefinitely. It has to be released. If it has to be released, then an earthquake has to be of magnitude more than eight or there are 20-30 earthquakes of more than seven," he said.

"However, this is unlikely and an earthquake, if it hits the region, could be of the magnitude of more than eight," Rai said.

He said that any major earthquake in Chamoli or Kumaon region could affect Delhi too as the city is in the line.

Rai said it was impossible to assign any time-frame to the calamity.

"However, a prediction based on general pattern of cyclicity of earthquakes shows that it is possible to have an earthquake of more than 7.5 magnitude after 180 years. The last such major earthquake had occurred in 1803 in that area," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 24,2020

Kochi, Apr 24: The central government on Thursday submitted a statement in the Kerala High Court on the three petitions challenging the contract between Kerala government and US-based data analytics company Sprinklr.

Assistant Solicitor General P Vijayakumar filed the statement on behalf of the central government, which is the second respondent in the case.

The statement said that the contract between the Kerala government and Sprinklr dilutes the rights of the people. It stated the contract does not specify the amount of compensation that individuals should receive in case of breach of privacy or misuse of information.

It also said that it was not clear whether the information was collected and handed over to the data analytics firm with full consent of the patients (suspected and otherwise).

''It is always preferable to utilise the services available in the government sector for sharing sensitive data required for analytical purposes.

The Government of India has introduced the 'Aarogya Setu' application for collection of health data and about seven crore Indian citizens have already downloaded the same. All the state governments are advised to promote the said application for fighting the pandemic," the statement said.

It was further submitted that the "Government of India with the support of NIC is capable of providing all the requirements relating to data storage, processing and application which are being offered the third respondent, if a request to that effect comes from the state government."

Kerala Congress leader Ramesh Chennithala and BJP state president K Surendran had earlier approached the Kerala High Court seeking cancellation of the state government's agreement with Sprinklr for processing of data related to COVID-19 patients.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 29,2020

New Delhi, Jun 29: Delhi Chief Minister Arvind Kejriwal on Monday paid tribute to the senior doctor of city government-run LNJP Hospital who died battling COVID-19, saying the society has "lost a very valuable fighter".

The 52-year-old doctor served in the front line of the war against the pandemic at the government facility, and died of novel coronavirus infection in an ICU of a private hospital on Sunday.

"Dr Aseem Gupta, a senior doctor of LNJP Hospital succumbed to Covid yday. He was known for going out of his way to serve his patients. We have lost a very valuable fighter. Delhi salutes his spirit and sacrifice...," Kejriwal tweeted.

The chief minister also said in his tweet that he has spoken to Dr Gupta''s wife and "offered my condolences and support".

LNJP Hospital is a dedicated COVID-19 facility under the Delhi government. It recently completed 100 days of being declared a coronavirus facility.

"LNJP Hospital has displayed great fortitude in the face of acute challenges. It''s recovery rate is going up, death rate is reducing, ICU capacity is being ramped up - the hospital is saving so many lives," the chief minister said.

A condolence meeting to pay respect to Dr Gupta has been scheduled at 1 pm in the office of the Medical Director of the hospital, a senior official said.

The doctor, a consultant anaesthesiologist died at the Max hospital, Saket in south Delhi, a private dedicated COVID-19 facility.

"He was a front line anaesthesia specialist who contracted COVID-19 infection while on duty. He tested positive on June 6, when he had mild symptoms and was shifted to a quarantine facility. His symptoms aggravated on June 7 and he was admitted in the Intensive Care Unit of the LNJP Hospital," the LNJP Hospital said in a statement on Sunday.

He was shifted to Max Hospital, Saket on June 8 on his request, it said.

The doctor was battling the disease for the last two weeks at Max Hospital, where he succumbed to the illness on Sunday, the statement said.

He was Specialist, Grade I, in the Department of Anaesthesia at the LNJP Hospital, the statement said.

Several hundreds of healthcare workers have been infected with COVID-19 till date in Delhi.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.